Targeting a Targeted Drug: An Approach Toward Hypoxia-Activatable Tyrosine Kinase Inhibitor Prodrugs.
Karnthaler-Benbakka C, Groza D, Koblmüller B, Terenzi A, Holste K, Haider M, Baier D, Berger W, Heffeter P, Kowol CR, Keppler BK.
Karnthaler-Benbakka C, et al. Among authors: keppler bk.
ChemMedChem. 2016 Nov 7;11(21):2410-2421. doi: 10.1002/cmdc.201600417. Epub 2016 Oct 5.
ChemMedChem. 2016.
PMID: 27706901
Free PMC article.